To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Consortium invests $145m in specialty pharma
MPM Capital and LLR Partners have led a Series D financing round totaling $50 million in equity and $95 million in debt for acute-care company EKR Therapeutics.
